image: Professor Jae-Seok Min of the Division of Foregut Surgery, Department of Surgery, at Korea University Anam Hospital
Credit: KU Medicine
Nationwide analysis of 855 patients cautions against assuming that less extensive lymph node dissection
is inherently safer
Findings emphasize individualized surgical decisions and careful perioperative management,
including pneumonia prevention
A research team led by Professor Jae-Seok Min of the Division of Foregut Surgery, Department of Surgery, at Korea University Anam Hospital and Professor Sang-Ho Jeong of the Department of Surgery at Gyeongsang National University Changwon Hospital examined the association between lymph node dissection and short-term outcomes after palliative, non-curative gastrectomy for stage IV gastric cancer. A higher number of retrieved lymph nodes was not associated with higher rates of complications or mortality within 30 days of surgery. However, the researchers emphasized that these observational findings do not establish that more extensive lymph node dissection is safer or provides a therapeutic benefit.
Systemic anticancer therapy is the mainstay of treatment for stage IV gastric cancer. For selected patients with symptoms such as bleeding or gastric outlet obstruction that prevents adequate food intake, palliative gastrectomy may be considered to relieve symptoms. Although limiting lymph node dissection is often assumed to reduce surgical risk, evidence supporting this assumption remains limited.
The team analyzed 855 patients with pathologically confirmed stage IV gastric cancer who underwent palliative gastrectomy, identified from 26,828 cases in the Korean Gastric Cancer Association’s nationwide survey registries for 2019 and 2023. Patients were classified according to the number of retrieved lymph nodes: fewer than 15 nodes in the limited-dissection group (62 patients) and 15 or more in the extended-dissection group (793 patients). This classification was based on lymph node counts rather than a direct comparison of anatomical D1 and D2 dissection.
Before statistical adjustment, the 30-day complication rates were 43.5% in the limited-dissection group and 29.8% in the extended-dissection group. The corresponding 30-day mortality rates were 17.7% and 6.8%. However, the limited-dissection group included a higher proportion of patients with poorer preoperative physical status, as well as more patients undergoing open surgery or total gastrectomy. This pattern may reflect preferential selection of limited dissection for patients perceived to be at higher surgical risk.
To account for measured differences between the groups, the researchers applied propensity score weighting based on age, sex, body mass index, American Society of Anesthesiologists physical status, comorbidities, neoadjuvant chemotherapy, surgical approach, extent of gastric resection, and combined organ resection. The weighted 30-day complication rates were 45.1% in the limited-dissection group and 30.9% in the extended-dissection group, while weighted mortality rates were 19.7% and 7.8%, respectively. Additional adjusted regression analyses also showed an association between extended dissection and lower odds of complications and mortality.
The researchers cautioned that these associations should not be interpreted as evidence that removing more lymph nodes improves surgical outcomes. Residual confounding by indication—including differences in patient frailty, nutritional status, disease burden, and the circumstances leading to the choice of surgery—may help explain the observed results. The findings therefore challenge the assumption that limiting lymph node dissection alone necessarily makes palliative gastrectomy safer.
In the descriptive analysis of individual complications, pneumonia showed the largest weighted difference between the groups: 14.8% in the limited-dissection group versus 3.7% in the extended-dissection group. Anastomotic leakage, duodenal stump leakage, and intra-abdominal abscess were also numerically more frequent in the limited-dissection group, although their between-group differences were smaller than that observed for pneumonia. Because event counts were sparse, these complication-specific comparisons were reported descriptively and do not support reliable conclusions about statistical significance. They also do not establish that the extent of lymph node dissection caused the observed differences.
“Our study does not mean that removing more lymph nodes during palliative gastrectomy for stage IV gastric cancer reduces complication rates,” Professor Min said. “Rather than assuming that limiting lymph node dissection will lower surgical risk, treatment decisions should be based on a comprehensive assessment of the patient’s overall health, disease extent, and ability to receive subsequent anticancer therapy. Careful perioperative management, including attention to pneumonia prevention, is also essential.”